{"id":"https://openalex.org/W4388300266","doi":"https://doi.org/10.1002/slct.202302235","title":"Exploring the Potential of Vortioxetine Derivatives as Inhibitors of SARS\u2010CoV\u20102 Main Protease: A Computational Study","display_name":"Exploring the Potential of Vortioxetine Derivatives as Inhibitors of SARS\u2010CoV\u20102 Main Protease: A Computational Study","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4388300266","doi":"https://doi.org/10.1002/slct.202302235"},"language":"en","primary_location":{"id":"doi:10.1002/slct.202302235","doi":"https://doi.org/10.1002/slct.202302235","is_oa":false,"landing_page_url":"https://doi.org/10.1002/slct.202302235","pdf_url":null,"source":{"id":"https://openalex.org/S4210221416","display_name":"ChemistrySelect","issn_l":"2365-6549","issn":["2365-6549"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemistrySelect","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101296125","display_name":"Aizhen Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144367","display_name":"Zhejiang Pharmaceutical College","ror":"https://ror.org/04s9pf004","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210144367"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Aizhen Zhou","raw_affiliation_strings":["Zhejiang Pharmaceutical University, Ningbo, 315000 China","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Pharmaceutical University, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210144367"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Li Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143588","display_name":"Ningbo College of Health Sciences","ror":"https://ror.org/041tqx430","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210143588"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Wang","raw_affiliation_strings":["NingBo College of Health Sciences, Ningbo, 315000 China","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NingBo College of Health Sciences, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210143588"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100436916","display_name":"Jie Zou","orcid":"https://orcid.org/0009-0008-9437-376X","observed_orcids":["https://orcid.org/0009-0008-9437-376X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Zou","raw_affiliation_strings":["Ningbo Haishu District Hospital of Traditional Chinese Medicine, Ningbo, 315000 China","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ningbo Haishu District Hospital of Traditional Chinese Medicine, Ningbo, 315000 China","institution_ids":[]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110680273","display_name":"Shuwei Ma","orcid":"https://orcid.org/0009-0007-4520-193X","observed_orcids":["https://orcid.org/0009-0007-4520-193X"]},"institutions":[{"id":"https://openalex.org/I4210144367","display_name":"Zhejiang Pharmaceutical College","ror":"https://ror.org/04s9pf004","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210144367"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuwei Ma","raw_affiliation_strings":["Zhejiang Pharmaceutical University, Ningbo, 315000 China","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Pharmaceutical University, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210144367"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026716968","display_name":"Yahong Zhou","orcid":"https://orcid.org/0000-0002-2482-1976","observed_orcids":["https://orcid.org/0000-0002-2482-1976"]},"institutions":[{"id":"https://openalex.org/I4210144367","display_name":"Zhejiang Pharmaceutical College","ror":"https://ror.org/04s9pf004","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210144367"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yahong Zhou","raw_affiliation_strings":["Zhejiang Pharmaceutical University, Ningbo, 315000 China","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Pharmaceutical University, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210144367"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100347438","display_name":"Juan Wang","orcid":"https://orcid.org/0009-0002-7957-0833","observed_orcids":["https://orcid.org/0009-0002-7957-0833"]},"institutions":[{"id":"https://openalex.org/I4210144367","display_name":"Zhejiang Pharmaceutical College","ror":"https://ror.org/04s9pf004","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210144367"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Juan Wang","raw_affiliation_strings":["Zhejiang Pharmaceutical University, Ningbo, 315000 China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Pharmaceutical University, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210144367"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108047832","display_name":"Na Li","orcid":"https://orcid.org/0000-0002-9578-2871","observed_orcids":["https://orcid.org/0000-0002-9578-2871"]},"institutions":[{"id":"https://openalex.org/I4210144367","display_name":"Zhejiang Pharmaceutical College","ror":"https://ror.org/04s9pf004","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210144367"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Na Li","raw_affiliation_strings":["Zhejiang Pharmaceutical University, Ningbo, 315000 China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Pharmaceutical University, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210144367"]}]},{"author_position":"last","author":{"id":null,"display_name":"Bin Cheng","orcid":"https://orcid.org/0000-0001-5791-1719","observed_orcids":["https://orcid.org/0000-0001-5791-1719"]},"institutions":[{"id":"https://openalex.org/I4210144367","display_name":"Zhejiang Pharmaceutical College","ror":"https://ror.org/04s9pf004","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210144367"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Bin Cheng","raw_affiliation_strings":["Zhejiang Pharmaceutical University, Ningbo, 315000 China"],"raw_orcid":"https://orcid.org/0000-0001-5791-1719","affiliations":[{"raw_affiliation_string":"Zhejiang Pharmaceutical University, Ningbo, 315000 China","institution_ids":["https://openalex.org/I4210144367"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210144367"],"apc_list":{"value":3660,"currency":"USD","value_usd":3660},"apc_paid":null,"fwci":0.087,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.25731694,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"8","issue":"41","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/main-protease","display_name":"main protease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/3cl-protease-inhibitors","display_name":"3CL protease inhibitors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8640000224113464},{"id":"https://openalex.org/keywords/comfa","display_name":"CoMFA","score":0.9459999799728394},{"id":"https://openalex.org/keywords/comsia","display_name":"CoMSIA","score":0.9980000257492065},{"id":"https://openalex.org/keywords/3d-qsar","display_name":"3D-QSAR","score":0.9639999866485596},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.7860000133514404},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.8109999895095825},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.8880000114440918},{"id":"https://openalex.org/keywords/mm-pbsa","display_name":"MM-PBSA","score":0.7350000143051147},{"id":"https://openalex.org/keywords/binding-free-energy","display_name":"binding free energy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/antiviral-drug-design","display_name":"antiviral drug design","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5858163237571716},{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.5677564144134521},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5420920848846436},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.5382828712463379},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.47172823548316956},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4534284770488739},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.44255533814430237},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.43696457147598267},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.424185574054718},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.35954225063323975},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.33265796303749084},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1825748085975647},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15825486183166504},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11522704362869263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.09298741817474365},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.08531296253204346},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.0},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/slct.202302235","doi":"https://doi.org/10.1002/slct.202302235","is_oa":false,"landing_page_url":"https://doi.org/10.1002/slct.202302235","pdf_url":null,"source":{"id":"https://openalex.org/S4210221416","display_name":"ChemistrySelect","issn_l":"2365-6549","issn":["2365-6549"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemistrySelect","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1968984443","https://openalex.org/W2009867031","https://openalex.org/W2061171782","https://openalex.org/W2135686166","https://openalex.org/W2171268876","https://openalex.org/W2346597486","https://openalex.org/W2527129695","https://openalex.org/W2559861474","https://openalex.org/W2583149323","https://openalex.org/W2593436234","https://openalex.org/W2786455005","https://openalex.org/W2920835902","https://openalex.org/W2941921367","https://openalex.org/W2955815434","https://openalex.org/W3015608194","https://openalex.org/W3015674841","https://openalex.org/W3020300207","https://openalex.org/W3087924281","https://openalex.org/W3113166651","https://openalex.org/W3120256965","https://openalex.org/W3129531632","https://openalex.org/W3139690347","https://openalex.org/W3152703278","https://openalex.org/W3187903101","https://openalex.org/W3202287440","https://openalex.org/W3210841350","https://openalex.org/W4211218744","https://openalex.org/W4223587435","https://openalex.org/W4224260488","https://openalex.org/W4229031028","https://openalex.org/W4280632020","https://openalex.org/W4284886800","https://openalex.org/W4285028040","https://openalex.org/W4312852715","https://openalex.org/W4362700680"],"related_works":["https://openalex.org/W4229031028","https://openalex.org/W7215987231","https://openalex.org/W3198838632","https://openalex.org/W4393143878","https://openalex.org/W4295743134","https://openalex.org/W4223601146","https://openalex.org/W4324381693","https://openalex.org/W4414268146","https://openalex.org/W7164491708","https://openalex.org/W4412077433"],"abstract_inverted_index":{"Abstract":[0],"In":[1,16],"recent":[2],"years,":[3],"Vortioxetine":[4,24],"derivatives":[5,25],"have":[6,52],"attracted":[7],"much":[8],"attention":[9],"as":[10],"main":[11,175],"protease":[12],"inhibitors":[13,171],"of":[14,22,63,77,96,123,167],"SARS\u2010CoV\u20102.":[15],"this":[17],"study,":[18],"the":[19,61,74,78,90,97,104,121,124,129,142,163,173],"structure\u2010activity":[20],"relationship":[21],"32":[23],"was":[26,107],"studied":[27],"by":[28,86,100,112],"CoMFA":[29,37],"and":[30,44,56,71,88,116,165,169],"CoMSIA":[31,45],"models.":[32],"The":[33,154],"results":[34],"show":[35],"that":[36,73,141],"(q":[38,46],"2":[39,42,47,50],"=0.522,":[40],"r":[41,49],"=0.996)":[43],"=0.562,":[48],"=0.934)":[51],"good":[53],"estimation":[54],"stability":[55],"prediction":[57],"ability.":[58],"Subsequently,":[59],"through":[60],"analysis":[62],"3D\u2010QSAR":[64],"model,":[65],"we":[66],"designed":[67,144],"four":[68],"novel":[69],"compounds,":[70],"verified":[72,89,120],"pharmacokinetic":[75],"properties":[76],"new":[79,98,105,125],"molecules":[80,106,126,146],"were":[81],"superior":[82],"to":[83],"compound":[84,110],"28":[85,111],"ADMET,":[87],"key":[91],"amino":[92],"acid":[93],"action":[94],"sites":[95],"molecule":[99],"molecular":[101,113],"docking.":[102],"Finally,":[103],"compared":[108],"with":[109],"dynamics":[114],"simulation":[115],"MMPBSA,":[117],"which":[118],"further":[119],"efficacy":[122],",":[127],"wherein":[128],"binding":[130],"free":[131],"energy":[132],"N1":[133],"(\u0394G=\u2212161.38":[134],"kJ/mol)>N4":[135],"(\u0394G=\u2212154.19":[136],"kJ/mol)>C28":[137],"(\u0394G=\u2212129.13":[138],"kJ/mol),":[139],"indicating":[140],"newly":[143],"drug":[145],"are":[147],"more":[148],"suitable":[149],"for":[150,162],"subsequent":[151],"experimental":[152],"verification.":[153],"findings":[155],"presented":[156],"herein":[157],"can":[158],"offer":[159],"valuable":[160],"guidance":[161],"design":[164],"development":[166],"efficacious":[168],"innovative":[170],"targeting":[172],"SARS\u2010CoV\u20102":[174],"protease.":[176]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-04T00:00:00"}